Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-31

Clinical Trial Update: Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

View source ↗

Summary

Pfizer-sponsored trial investigating characteristics of patients with moderately active rheumatoid arthritis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2013-10-31